SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDairy Crest Regulatory News (DCG)

  • There is currently no data for DCG

Trading Statement

18 Sep 2017 07:00

RNS Number : 9203Q
Dairy Crest Group PLC
18 September 2017
 

18 September 2017

 

Dairy Crest Group plc ("Dairy Crest")

 

TRADING UPDATE FOR THE SIX MONTHS ENDING 30 SEPTEMBER 2017

 

Dairy Crest is issuing the following pre-close trading update for the six months ending30 September 2017, ahead of announcing its Interim Results on 9 November 2017.

 

Trading update

In the first half of the financial year we expect that combined volumes of our four key brands - Cathedral City, Clover, Country Life and Frylight - will be ahead of last year. Combined value growth of these brands is expected to be higher than volume growth. Cathedral City, the UK's leading cheese brand, is expected to deliver double-digit volume growth in the first half.

 

Cathedral City, Clover and Frylight continue to show strong volume growth. As previously stated, as a result of higher cream prices, which determine input costs for the butter business, we have reduced promotional activity on Country Life. Whilst this has impacted sales volumes, it has partly mitigated the adverse impact on margins.

 

In conjunction with our partner, Fonterra, we continue to make good progress developing the customer base for our demineralised whey and galacto-oligosaccharide. We will start to benefit from this in the second half of the year.

 

Pension fund

As previously announced on 8 September, the 2016 actuarial valuation for the Dairy Crest Group Pension Fund (the "Pension Fund") is now agreed and incorporates a change in indexation from RPI to CPI. This change in indexation will result in an exceptional gain in 2017/18 estimated to be approximately £125 million.

 

The actuarial deficit of £100 million at March 2016 represents a reduction of £45 million compared to the March 2013 valuation, despite significantly lower gilt yields. Furthermore, deficit reduction contributions will be £10 million and £15 million in 2017/18 and 2018/19 respectively; a reduction of £12 million across these two years compared to the 2013 contributions schedule. They will revert to £20 million in 2019/20 although March 2019 is the date of the next full actuarial valuation and schedule of contributions.Profit and financial position

We expect profit for the half year to be ahead of the same period last year. Our expectations for the full year remain unchanged.

 

As normal, we anticipate that Dairy Crest's net debt at the half year will be higher than at the year-end in March 2017 as the first half is characterised by increased stock levels due to the seasonality of milk supply and the payment of the final dividend. However, we remain on track to deliver a reduction in net debt for the full year.

 

Mark Allen, Chief Executive, commented:

 

"Cathedral City has had a strong first half of the year, delivering good volume and value growth and strengthening its position as the nation's favourite cheese. This performance has more than offset the impact of further input cost inflation in the butter business.

 

"Overall, first half profits are expected to be ahead of last year. Our profit expectations for the full year are unchanged despite input costs remaining high. The strength of our brands and focus on quality, innovation and efficiencies mean that we remain well positioned to deal with market conditions.

 

"We continue to focus on cash generation and on reducing net debt in the full year. The agreement reached with the Trustee of the Pension Fund is an important development and significantly reduces future funding liabilities."

 

 

ENDS

 

Dairy Crest is hosting a site visit for analysts and investors to its National Distribution Centre in Nuneaton on Monday 18 and Tuesday 19 September 2017. The management team will make presentations on this trading update, key brands, innovation and our supply chain. These will be made available on Dairy Crest's website at www.dairycrest.co.uk/investors. No material new information will be disclosed in these presentations.

 

Dairy Crest expects to issue its Interim Results for the six months ending 30 September 2017 on 9 November 2017.

 

 

For further information:

 

Investors/Analysts

Tom Atherton Group Finance Director, Dairy Crest 01372 472264

 

Media

Tim Danaher / Oliver Hughes Brunswick 020 7404 5959

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFIVALIELID
Date   Source Headline
31st Jan 201811:43 amRNSTotal Voting Rights & Capital
31st Jan 20187:00 amRNSTrading Update
26th Jan 20182:51 pmRNSDirector/PDMR Shareholding
18th Jan 20183:53 pmRNSDirector and PCA Dealing
17th Jan 20187:00 amRNSExecutive Director Notification
9th Jan 201810:28 amRNSDirector / PDMR Shareholding
3rd Jan 20183:39 pmRNSDirector/PDMR Shareholding
2nd Jan 20189:38 amRNSTotal Voting Rights & Capital
5th Dec 20179:29 amRNSTR-1
30th Nov 201710:43 amRNSTotal Voting Rights & Capital
28th Nov 20177:00 amRNSNon-Executive Director Appointment
22nd Nov 20172:17 pmRNSStandard form for notification of major holdings
20th Nov 201710:40 amRNSDirector/PDMR Shareholding
13th Nov 201710:28 amRNSStandard form for notification of major holdings
9th Nov 20177:00 amRNSInterim Results
3rd Nov 20171:56 pmRNSTotal Voting Rights
2nd Oct 20177:00 amRNSTotal Voting Rights
21st Sep 201712:11 pmRNSTR-1: form for notification of major holdings
18th Sep 20177:00 amRNSTrading Statement
8th Sep 20177:00 amRNSActuarial valuation agreed for the pension fund
4th Sep 20172:37 pmRNSDirector / PDMR Shareholding
31st Aug 20171:42 pmRNSTotal Voting Rights
17th Aug 20172:03 pmRNSDirector / PDMR Shareholding
15th Aug 201710:15 amRNSDirector/PDMR Shareholding
9th Aug 201710:12 amRNSBLOCK LISTING SIX MONTHLY REVIEW
31st Jul 201712:11 pmRNSTotal Voting Rights & Capital
18th Jul 20174:51 pmRNSResults of Annual General Meeting
18th Jul 20177:00 amRNSAGM and Interim Management Statement
7th Jul 20171:36 pmRNSDirector/PDMR Shareholding
30th Jun 20172:30 pmRNSTotal Voting Rights
30th Jun 201711:15 amRNSTotal Voting Rights
16th Jun 201710:43 amRNS2017 Annual Report & Accounts & Notice of AGM
2nd Jun 201710:36 amRNSTotal Voting Rights
26th May 20173:54 pmRNSDirector / PDMR Shareholding
19th May 201712:47 pmRNSBlock Listing Six Monthly Review
18th May 20177:00 amRNSPreliminary Results
28th Apr 201710:40 amRNSTotal Voting Rights
12th Apr 201712:02 pmRNSNotification of Major Interest in Shares
31st Mar 20179:21 amRNSTotal Voting Rights & Capital
2nd Mar 20173:16 pmRNSTotal Voting Rights
9th Feb 20177:00 amRNSInterim Management Statement
31st Jan 201711:29 amRNSTotal Voting Rights & Capital
27th Jan 201712:51 pmRNSDirector/PDMR Shareholding
10th Jan 20171:38 pmRNSDirector / PDMR Shareholding
10th Jan 20171:27 pmRNSDirector / PDMR Shareholding
10th Jan 20171:24 pmRNSDirector / PDMR Shareholding
3rd Jan 201710:59 amRNSTotal Voting Rights
21st Dec 20167:00 amRNSDairy Crest announces research partnership
30th Nov 201612:58 pmRNSTotal Voting Rights & Capital
24th Nov 20161:02 pmRNSBLOCK LISTING SIX MONTHLY REVIEW

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.